Abstract
T he recent withdrawal of rofecoxib (Vioxx) from the worldwide market has focused intense public scrutiny on drug safety. Although the US Food and Drug Administration monitors drug safety after...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have